Full-Time

Therapy Development Director

Posted on 7/1/2024

ReCor Medical

ReCor Medical

51-200 employees

Develops ultrasound technology for hypertension treatment

Compensation Overview

$180k - $205k/yr

Senior, Expert

United States

Onsite presence required in the United States.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Sales
Communications
Management
Marketing
Requirements
  • Bachelor’s Degree or equivalent four (4) year clinical degree in Life Sciences or related field, or equivalent work experience (MBA is a plus)
  • 10+ years of medical sales & leadership experience
Responsibilities
  • Lead the team of Therapy Development Territory Managers (TDTM) that will launch Paradise (Ultrasound Renal Denervation System), the first ever renal denervation product into the market.
  • Recognize, Hire, train, develop, coach and retain high caliber Therapy Development Territory Managers who are committed to excellence in performance, people management, customer care and partner relationship building in support of achieving business objectives
  • Work closely with senior management to set the culture and strategic direction
  • Ensure the TD field team is properly credentialed at all hospitals for vendor credentialing and has access/good standing to hospitals
  • Develop and maintain a high performing organization
  • Oversee district structure/organizational planning; identify qualified accounts and proper order of rollout with territory alignment and compensation considerations
  • Manage individual territory customer interface while on boarding talent
  • Oversee all performance management responsibilities; feedback/coaching, development planning, employee training, objective setting, performance reviews, etc. in support of the therapy development staff
  • Manage and achieve annual operating planning/quota, budgeting and forecasting for the therapy development team within the district
  • Partner with colleagues in Medical and Scientific Affairs and Marketing on key deliverables, health economic models, and working with the markets to plan and implement studies based on local business plans
  • Expertise with subject matters involving healthcare economics, upstream and downstream product portfolio, clinical data and the competitive marketplace
  • Be able to identify and differentiate root cause of patient access restrictions between outreach and patient pathway
  • Establish an understanding of referral dynamics and how patient access may be restricted or delayed
  • Ensure the field reports all product and procedure complaints to the appropriate departments according to ReCor Medical policy
  • Ensure TD team/staff is trained and abides by ReCor Medical’s mission and ethics policies, and business conduct standards
  • Document formal field travel within district with proper follow-up and quarterly TDTM reports
  • Provide ongoing coaching and feedback to Sales and Therapy Development teams through field visits, observation, and measurement of results. Performance responsibility includes safe growth with outcome accountability
  • Establish plan quotas for each territory in region; ensure that strategies are in place to meet and exceed plan
  • Ensure all sales and marketing programs are communicated and implemented and coordinated
  • Drive teamwork between ReCor’s Sales & Therapy Development organization and other internal constituencies to improve communication and sharing of information and resources
  • Monitor and control expenses to include proper allocation of customer inventory
  • Develop, maintain and provide solutions for customer business needs
  • Effectively build a positive working relationship between ReCor Medical and key accounts
  • Attend/develop curriculum for quarterly district TD & Sales meetings and attend key society conventions as requested
  • Communicate developments in best practice techniques and technologies, impact of education programs, competitive activities, and customer response back to the business (GM, VP’s)
  • Cultivate and maintain excellent internal professional relationships with education, marketing, clinical, regulatory, quality, supply and R&D teams

ReCor Medical focuses on treating hypertension, a condition that affects over 1 billion people globally. The company has created the Paradise System, which utilizes non-focused ultrasound technology to perform renal denervation, a procedure that targets kidney nerves to help lower blood pressure. This system is particularly beneficial for patients who do not respond well to standard blood pressure medications. ReCor Medical is dedicated to clinical research and development to ensure the safety and effectiveness of its technology, and it generates revenue through the sale of its medical devices and partnerships with healthcare providers. The company is also involved in significant clinical trials, such as the RADIANCE Global Program, aimed at validating the benefits of renal denervation for hypertension treatment. ReCor Medical's goal is to provide a new treatment option for high blood pressure, addressing a major global health issue.

Company Size

51-200

Company Stage

Debt Financing

Total Funding

$40M

Headquarters

Palo Alto, California

Founded

2009

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA approval boosts credibility and market entry for ReCor's Paradise System.
  • Global renal denervation market projected to grow at 35% CAGR until 2030.
  • Increased demand for non-pharmacological hypertension treatments benefits ReCor.

What critics are saying

  • Competition from Medtronic could impact ReCor's market share and pricing.
  • New CEO may lead to strategic shifts disrupting current operations.
  • Reliance on clinical trials poses risks if results don't meet expectations.

What makes ReCor Medical unique

  • ReCor Medical's Paradise System uses non-focused ultrasound for renal denervation.
  • The company targets hypertension patients unresponsive to traditional medications.
  • ReCor is involved in the RADIANCE Global Program for clinical validation.

Help us improve and share your feedback! Did you find this helpful?

Company News

PR Newswire
May 17th, 2024
Recor Medical Champions Global Action On World Hypertension Day: Early Intervention And Continued Innovation Crucial In Tackling This Silent Killer Impacting Billions Worldwide

FRANKFURT, GERMANY and PALO ALTO, Calif. , May 17, 2024 /PRNewswire/ -- Hypertension, or high blood pressure, affects one in three Europeans over the age of 30 and more than one billion people worldwide. Hypertension is known as the "silent killer" because many people do not know they have it and, over time, it can lead to serious health issues. Hypertension is the number one contributor to the burden of human disease globally, has been associated with a five-year reduction in life expectancy and is a major risk factor for heart disease, stroke, heart attacks and other serious health problems.Bloodpressure Measurement is important with HypertensionMay 17 is World Hypertension Day, a global initiative to highlight the importance of monitoring blood pressure and provide education about this devastating chronic disease. Recor Medical – the pioneer of the Paradise™ Ultrasound Renal Denervation (uRDN) System, a recently FDA-approved medical device-based procedure to treat hypertension – is joining the fight by promoting awareness and encouraging continued innovation and equitable access to early intervention and sustainable solutions for patients suffering from this chronic disease.According to a report from the World Health Organization, the number of adults with hypertension doubled between 1990 and 2019 from 650 million to 1.3 billion. The report also states that only 54 percent of adults with hypertension are diagnosed and only 42 percent receive treatment

PR Newswire
May 17th, 2024
Recor Medical Soutient Des Actions Mondiales À L'Occasion De La Journée Mondiale De L'Hypertension : L'Intervention Précoce Et L'Innovation Continue Sont Les Clés De La Lutte Contre Ce Tueur Silencieux Qui Affecte Des Milliards De Personnes Dans Le Monde

FRANCFORT, ALLEMAGNE and PALO ALTO, Calif., 17 mai 2024 /PRNewswire/ -- L'hypertension artérielle, ou HTA, touche un Européen sur trois de plus de 30 ans et plus d'un milliard de personnes dans le monde. L'hypertension est appelée le "tueur silencieux" parce que de nombreuses personnes ne savent pas qu'elles en souffrent et qu'elle peut entraîner de graves problèmes de santé au fil du temps. L'hypertension est le premier facteur contribuant à la charge de morbidité mondiale et a été associée à une réduction de cinq ans de l'espérance de vie. Elle constitue un facteur de risque majeur pour les maladies cardiaques, les accidents vasculaires cérébraux, les crises cardiaques et d'autres problèmes de santé graves.Bloodpressure Measurement is important with HypertensionLe 17 mai est la Journée mondiale de l'hypertension, une action mondiale visant à souligner l'importance du contrôle de la tension artérielle et à sensibiliser à cette maladie chronique aux conséquences graves. Recor Medical - le pionnier du système Paradise™ Ultrasound Renal Denervation (uRDN), une technique médicale récemment approuvée par la FDA pour le traitement de l'hypertension artérielle - participe à cet appel en sensibilisant les gens à cette maladie et en encourageant davantage d'innovations et un accès équitable à une intervention précoce et à des solutions durables pour les patients qui souffrent de cette maladie chronique.Selon un rapport de l'Organisation mondiale de la santé, le nombre d'adultes souffrant d'hypertension a doublé entre 1990 et 2019, passant de 650 millions à 1,3 milliard. Le rapport indique également que seuls 54 % des adultes souffrant d'hypertension sont diagnostiqués et que seuls 42 % reçoivent un traitement

PR Newswire
May 17th, 2024
Recor Medical Unterstützt Weltweite Aktionen Zum Welt-Hypertonie-Tag: Frühzeitige Intervention Und Kontinuierliche Innovation Sind Der Schlüssel Zur Bekämpfung Des Stillen Killers, Von Dem Milliarden Menschen Weltweit Betroffen Sind

FRANKFURT, GERMANY and PALO ALTO, Calif., 17. Mai 2024 /PRNewswire/ -- Bluthochdruck, auch Hypertonie genannt, betrifft einen von drei Europäern über 30 Jahre und mehr als eine Milliarde Menschen weltweit. Er wird auch als "stiller Killer" bezeichnet, weil viele Menschen nicht wissen, dass sie daran leiden, und er im Laufe der Zeit zu ernsthaften gesundheitlichen Problemen führen kann. Bluthochdruck ist weltweit der größte Verursacher von Krankheiten und wird mit einer um fünf Jahre verringerten Lebenserwartung in Verbindung gebracht. Er ist ein wichtiger Risikofaktor für Herzkrankheiten, Schlaganfälle, Herzinfarkte und andere schwerwiegende Gesundheitsprobleme.Bloodpressure Measurement is important with HypertensionDer 17. Mai ist der Welt-Hypertonie-Tag, eine weltweite Aktion, die auf die Wichtigkeit der Blutdruckkontrolle hinweist und über diese folgenschwere chronische Krankheit aufklärt

Meta Medical Solutions
Nov 13th, 2023
Recor Medical introduces Paradise uRDN system in US

Recor Medical introduces Paradise uRDN system in US.

MD+DI
Nov 8th, 2023
FDA Approves Renal Denervation for High Blood Pressure

Recor has been developing the Paradise renal denervation system for the treatment of hypertension since 2009.

INACTIVE